The injection is given intramuscularly, usually into the upper arm (deltoid) or buttock (gluteal muscle)
Research Mechanism In laboratory settings, GHK-Cu is utilised to investigate: ECM Remodeling: The balance between breaking down old, damaged collagen (via metalloproteinases) and synthesising new, healthy connective tissue
Another common use is as an adjunct in managing neuropathy due to diabetes or medication effects, when a clinician identifies or suspects a coexisting deficiency
We go to great lengths to ensure that
For Dihexa to progress in Alzheimer's research, several conditions would need to be met: Earlier intervention: Testing in cognitively normal individuals at high risk, or mild cognitive impairment, rather than established dementia Bioavailability optimization: Development of oral formulations with superior brain penetration, or better-tolerated intravenous regimens Combination approaches: Testing Dihexa alongside amyloid-targeting drugs or tau-focused therapeutics Mechanism refinement: Understanding which aspects of HGF signalling are beneficial versus which drive cancer risk concerns Patient stratification: Identifying subgroups (by genetics, biomarker status, disease stage) most likely to respond Dose optimization: The LIFT-AD trial used specific doses
Table 1 provides detailed information on the mechanism of action of anti-AFs properties of studied PPs